摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(Cyclopropylmethyl)-5-ethylsulfonyl-2-(1-methylcyclopentyl)benzimidazole | 1319122-46-7

中文名称
——
中文别名
——
英文名称
1-(Cyclopropylmethyl)-5-ethylsulfonyl-2-(1-methylcyclopentyl)benzimidazole
英文别名
——
1-(Cyclopropylmethyl)-5-ethylsulfonyl-2-(1-methylcyclopentyl)benzimidazole化学式
CAS
1319122-46-7
化学式
C19H26N2O2S
mdl
——
分子量
346.494
InChiKey
LURAKQNBAVXOPJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.63
  • 拓扑面积:
    60.3
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    2-amino-1-(N-cyclopropylmethylamino)-4-(ethylsulfonyl)benzene 、 1-甲基-环戊烷羧酸三乙胺 作用下, 反应 16.0h, 生成 1-(Cyclopropylmethyl)-5-ethylsulfonyl-2-(1-methylcyclopentyl)benzimidazole
    参考文献:
    名称:
    Optimisation of a novel series of selective CNS penetrant CB2 agonists
    摘要:
    A series of benzimidazole CB2 receptor agonists were prepared and their properties investigated. Optimisation of the three benzimidazole substituents led to the identification of compound 23, a potent CB2 full agonist (EC50 2.7 nM) with excellent selectivity over the CB1 receptor (> 3000-fold). Compound 23 demonstrated good CNS penetration in rat. Further optimisation led to the identification of compound 34 with improved selectivity over hERG and excellent CNS penetration in rat. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.05.063
点击查看最新优质反应信息

文献信息

  • Optimisation of a novel series of selective CNS penetrant CB2 agonists
    作者:Christine Watson、Dafydd R. Owen、Denise Harding、Kana Kon-I、Mark L. Lewis、Helen J. Mason、Miyako Matsumizu、Takasuke Mukaiyama、Margarita Rodriguez-Lens、Akiko Shima、Mifune Takeuchi、Isabelle Tran、Tim Young
    DOI:10.1016/j.bmcl.2011.05.063
    日期:2011.7
    A series of benzimidazole CB2 receptor agonists were prepared and their properties investigated. Optimisation of the three benzimidazole substituents led to the identification of compound 23, a potent CB2 full agonist (EC50 2.7 nM) with excellent selectivity over the CB1 receptor (> 3000-fold). Compound 23 demonstrated good CNS penetration in rat. Further optimisation led to the identification of compound 34 with improved selectivity over hERG and excellent CNS penetration in rat. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多